Journal of Infectious Diseases and Therapeutic Research

ISSN: Under Process | Chief Editor: Dr. Pratima Parashar Pandey

View Editorial Board

About the Journal

Journal of Infectious Diseases and Therapeutic Research (JIDTR) is a peer-reviewed, open-access international journal dedicated to advancing scientific knowledge, clinical practice, and therapeutic innovations in the field of infectious diseases. The journal provides a platform for researchers, clinicians, and healthcare professionals to share high-quality research, evidence-based studies, and expert perspectives on the prevention, diagnosis, treatment, and control of infectious diseases.

Scope of the Journal

The journal covers a broad spectrum of topics including, but not limited to:

  • Emerging and re-emerging infectious diseases
  • Viral, bacterial, parasitic, and fungal infections
  • Antimicrobial resistance and stewardship
  • Novel therapeutic agents and vaccine development
  • Clinical trials and translational research
  • Infection prevention and control strategies
  • Global health, epidemiology, and outbreak management
  • Public health policies and pandemic preparedness

Aim and Objectives

The primary aim of the journal is to foster collaboration and innovation by publishing original research articles, systematic reviews, case reports, short communications, and clinical studies that contribute to the understanding and management of infectious diseases. The journal also seeks to bridge the gap between laboratory research and clinical applications, ensuring that new therapeutic insights are effectively translated into medical practice.

Why Publish with Us?

  • Global Reach: Open-access publishing ensures wide dissemination and visibility of research.
  • Rigorous Peer Review: Manuscripts undergo a double-blind peer review process to maintain high scientific standards.
  • Interdisciplinary Focus: Encourages collaboration between microbiologists, clinicians, epidemiologists, and public health experts.
  • Rapid Publication: Efficient editorial processes to ensure timely dissemination of research findings.
  • Indexing & Archiving: Articles are indexed in major scientific databases, ensuring long-term accessibility and citation impact.

Audience

The journal is intended for:

  • Infectious disease specialists
  • Clinical researchers and healthcare providers
  • Microbiologists and laboratory scientists
  • Epidemiologists and public health officials
  • Pharmaceutical and biotech professionals
  • Policy makers and global health organizations

Commitment to Quality & Ethics

The Journal of Infectious Diseases and Therapeutic Research upholds the highest standards of publication ethics, following COPE guidelines. We are committed to integrity, transparency, and the responsible dissemination of scientific knowledge that contributes to global health and well-being.

Vision:

To become a leading global forum for knowledge exchange and collaboration in infectious disease research and therapeutics, contributing to improved patient outcomes and strengthened public health systems worldwide.


1999$

Article Publishing Charge

2-3 days

Time to First Decision

15-18 days

Review Time

25-35 days

Submission to Acceptance

2.65

Impact Factor

Google Scholar Indexing

Plagiarism Check

Indexing

Editorial Letter
16 Feb 2026 Infectious disease

Addressing the Mpox Outbreak in Sierra Leone: A Call for Strengthened Public Health Infrastructure

Authors: Safayet Jamil 1*

Research Article
13 Sep 2025 Therapeutics

Analysis and Control of Antibiotic Dynamic Models

Authors: Lakshmi. N. Sridhar

Review Article
01 Nov 2025 Dermitology

Intoxicating Beverages and Dermatological Disorders in the End Times: Clinical, Social, and Theological Perspectives

Authors: Joachim, Aasiyah Muzaahim, Al Haarits Harrats, Amalia Tri Utami, Maryam Aali 'Imroon2, Aasiyah Muzaahim

Review Article
05 Jan 2026 Infectious

Vaginal dysbiosis

Authors: Bon L. I, Sitsko A.D, Chernik E.A, Maksimovich N. Ye

Research Article
12 Feb 2026 pharmocology

Accelerating Drug Discovery with Artificial Intelligence (AI): Smarter Steps and Faster Results

Authors: Vetkar P.D, Pawar C.S, Ubale A.T., Prabhu S.R, Patil S.R, Patel A.A., Kulkarni A.S

Review Article
16 Feb 2026 Immunology

Fungal Host Contribution and Anti-Microbial Resistance

Authors: Emmanuel Osei Addo, Klinogo Benson, Abubakari Abudu, Solomon Amankwaah Osei, Fiawotso Cornelius Elikem

Research Article
12 Feb 2026 pharmocology

AI in Drug Discovery: Transforming Medicine for the Future

Authors: Dichvalkar D.D, Prof. Kulkarni A.S., Prof. Babar C.V, Kolse S.S, Acharekar L.D, Banavalikar S.S, Chavan S.G

Research Article
16 Feb 2026 pharmocology

Structure-Based Docking Analysis of FDA Approved Antibiotics Targeting LipL32 Protein as a Potential Therapeutic Approach Against Leptospirosis

Authors: Vinoth Kumar S, Nepolean R, Ramesh K

Research Article
07 Jan 2026 pharmacology

Tannic Acid: A Multipurpose Polyphenol Integrating Conventional Medicine with Contemporary Biomedical Advancements - A Systematic Review

Authors: Angel Ojimaojo Ekele, Florence Ezinwa Nkemehule, Abimbola Mary Oluwajembola, Olaide Ayokunmi Oladosu5, Micheal Abimbola Oladosu, Moses Adondua Abah, Nathan Rimamsanati Yohanna, Njoku Leticia Oluomachi

Research Article
16 Feb 2026 Chronic kidney disease

Association between N-terminal pro-B-type natriuretic peptide levels and kidney function decline in patients with cardiovascular risk factors: A cross-sectional study

Authors: , Joy Chimuanya Nnanna, Moses Adondua Abah, Peace Ayirioritse Ighosewe, Ifeoluwa Emmanuel Adeniran, Angel Ojimaojo Ekele, John Chukwuemeka Obiazor, Donald Uchemdi Elue1, Olaide Ayokunmi Oladosu, Micheal Abimbola Oladosu, Oladapo Opeyemi, Michael Temitope Kadiri, Faith Nkem Rowland, Modinat Adebukola Adefisayo, Praise Tochukwu Nnanna, Micah Nnabuko Okwah

Research Article
02 Jan 2026 Pharmacology

An overview of Mouth Dissolving Tablets of an Antihypertensive Drug Atenolol

Authors: Dr. Amol Ubale, Madhuri Tarate, Dr. Vivek Tarate, Dr. Ziya Khan

No articles found.
No articles found.